Superczynski, Christopher

Superczynski, Christopher was paid $85K by Medicaid between Jan 2018 and Sep 2022, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.

33Billing provider infoSUPERCZYNSKI, CHRISTOPHER
LINCOLN, RI 02865

33aNPI1184621138assigned 07/06/2005

33bProvider typeInternal Medicine Physician

28Total paid$85K

24GClaims1,529

24DCodes billed11

24AFirst – last monthJan 2018 – Sep 2022

Compared with peers

Next to other Internal Medicine Physician providers in Rhode Island

Rank by total paid#90 of 386

Median peer was paid$15K

This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	366	$22K
2019	162	$9K
2020	305	$17K
2021	355	$21K
2022	341	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	54%	885	781	$46K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	33%	405	379	$28K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	7.4%	104	86	$6K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.2%	28	24	$2K
80061	Lipid panel	1.2%	19	14	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	13	13	$519.43
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	24	24	$439.86
36415	Collection of venous blood by venipuncture	<1%	13	13	$439.23
80051		<1%	12	12	$197.80
84460		<1%	13	13	$163.31
81001		<1%	13	13	$100.95

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.